abstract |
The current invention provides compounds of formula (1): wherein: one of Q 1 , Q 2 and Q 3 is S, and the other of two of Q 1 , Q 2 and Q 3 are —CR 1 —, which are inhibitors of PI3K-delta. These compounds are useful for treatment of conditions mediated by PI3K-delta, such as hematopoietic cancers, immune disorders, and bone resorption disorders. The invention further provides pharmaceutical compositions comprising a compound of formula (1) and methods of using these compounds and compositions to treat conditions mediated by PI3K-delta. |